Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001480097-15-000001
Filing Date
2015-02-09
Accepted
2015-02-09 13:57:26
Documents
1
Period of Report
2015-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3136
  Complete submission text file 0001480097-15-000001.txt   4848
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Issuer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 WEST STREET 3B NEW YORK NY 10004
Business Address
Chow Wilfred (Reporting) CIK: 0001480097 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32674 | Film No.: 15587864